[artículo] 
inThe Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.3 (Mayo - Junio) . - pp. 4-11

Título :	Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics) : Results From the Recruitment Phase of the PRELAPSE Trial
Tipo de documento:	texto impreso
Autores:	John M. Kane, Autor ; Nina R. Schooler, Autor ; Patricia Marcy, Autor
Fecha de publicación:	2019
Artículo en la página:	pp. 4-11
Idioma :	Inglés (eng)
Palabras clave:	Esquizofrenia - tratamiento, Acción prolongada, estudio PRELAPSE
Resumen:	To document the acceptability of treatment with long-acting injectable (LAI) antipsychotic medication to early-phase schizophrenia patients as demonstrated by enrollment in a cluster-randomized LAI clinical trial.
Link:	./index.php?lvl=notice_display&id=20826

[artículo] Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics) : Results From the Recruitment Phase of the PRELAPSE Trial [texto impreso] / John M. Kane, Autor ; Nina R. Schooler, Autor ; Patricia Marcy, Autor . - 2019 . - pp. 4-11.
Idioma : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2019 - Vol. 80 - No.3 (Mayo - Junio) . - pp. 4-11

Palabras clave:	Esquizofrenia - tratamiento, Acción prolongada, estudio PRELAPSE
Resumen:	To document the acceptability of treatment with long-acting injectable (LAI) antipsychotic medication to early-phase schizophrenia patients as demonstrated by enrollment in a cluster-randomized LAI clinical trial.
Link:	./index.php?lvl=notice_display&id=20826